Regional Variation in Antenatal Late Preterm Steroid Use Following the ALPS Trial.

ABSTRACT:

Importance

The publication of the Antenatal Late Preterm Steroids (ALPS) trial in February 2016 demonstrated that antenatal administration of betamethasone in the late preterm period (between 34 to 36 weeks of gestation) for individuals with a high risk of delivery decreased neonatal respiratory morbidity. National estimates have suggested the trial did change obstetric practice, but little is known if the evidence was adopted uniformly or equitably.

Objective

To assess regional variation in the use of late preterm steroids after the publication of the Antenatal Late Preterm Steroids (ALPS) Trial and to understand factors associated with a region's pace of adoption.

Design, setting, and participants

This cross-sectional study used US natality data from February 2015 t

SUBMITTER: Freret TS 

PROVIDER: S-EPMC10777258 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature